Positive US spot ETF flows streak; long-term holders accumulating; and Ripple bagging a MiCA CASP license in EU all paint a solid bullish case for XRP. However, the price chart is not hiding any danger zones.
XRP has spent weeks moving in step with the struggling broader crypto market. That pattern broke on July 6, when a single European approval changed everything.
Ripple secured a license years in the making, and traders responded almost immediately. The timing, scale, and source of this surge tell a bigger story.
ETF flows have struggled alongside the broader crypto market in recent weeks. XRP, however, continues its pattern of reacting sharply to external developments.
Ripple received its European Union (EU) crypto-asset service provider (CASP) license on July 6, becoming fully MiCA-compliant. Luxembourg's CSSF granted the authorization, unlocking regulated crypto services across all 30 EEA countries.
This milestone lets Ripple offer regulated payments to banks, fintech companies, and corporates directly. The license pairs with Ripple's existing electronic money institution (EMI) license under one regulatory umbrella.
This regulatory clarity triggered a sharp surge in institutional flows almost immediately. XRP ETF inflows hit 8.6 million dollars, its highest level in two months.
The last time inflows reached this level was in early May. Regulatory certainty appears to be the common thread driving both spikes.
Institutions typically wait for compliance clarity before committing significant capital to any asset. Ripple's full MiCA authorization removed that hesitation specifically for European allocators.
On-chain data suggests XRP's downside may be nearing exhaustion. NUPL sitting deep in the capitulation zone often signals seller fatigue.
Following historical patterns, this saturation typically precedes a reversal rather than further decline. Capitulation zones rarely sustain themselves once maximum pessimism gets priced in.
Strong support from long-term holders is helping keep the XRP price afloat. HODL Waves data shows this conviction building steadily over recent trading sessions.
On July 2, the 1-2 year holder concentration of XRP supply grew by 3%. Their share climbed to 15.2%, a meaningful jump within just days.
This growth came as the 6-12 month holder supply matured into the older cohort. Coins aging into long-term status often signal reduced selling pressure ahead.
Older holders typically carry outsized influence over price stability during uncertain periods. Their reluctance to sell, even during weakness, often anchors price against deeper drawdowns.
Their growing conviction, paired with fresh regulatory tailwinds, could support XRP's recovery attempt.
Bullish regulatory developments could support XRP's recovery, but improving investor sentiment remains the stronger catalyst. XRP continues trading within a descending wedge, a pattern often associated with bullish breakouts.
The immediate objective is reclaiming the 61.8% Fibonacci retracement level near $1.15. A decisive move above this resistance would confirm the breakout and strengthen the case for sustained upside. Rising market participation would further reinforce bullish momentum.
The Money Flow Index is trending higher while XRP's price remains relatively subdued, creating a bullish divergence. This pattern suggests buying pressure continues building beneath the surface despite limited price appreciation.
Growing capital inflows often precede stronger directional moves when resistance levels begin to weaken. If momentum continues improving, XRP could break above the descending wedge and target the next major resistance around $1.25.
The bullish outlook depends heavily on broader cryptocurrency market conditions. If market sentiment weakens and buyers lose momentum, XRP could struggle to sustain its recovery despite encouraging on-chain signals.
Initial support sits near $1.06, with the psychologically important $1.00 level representing a stronger defensive zone. Losing that support could trigger cascading liquidations and accelerate selling pressure, increasing the likelihood of a deeper corrective phase.
No comments yet
